{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:06:54Z","timestamp":1761109614899,"version":"3.40.5"},"reference-count":27,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,7,1]]},"abstract":"<jats:p>Background.\u2003Resolution ofHelicobacter pylori infection is important in the management of peptic ulcer disease and reduces peptic ulcer recurrence in both adults and children. Various anti-H pyloritreatment regimens have been proposed, reflecting the incomplete clinical success of each. A combination of omeprazole, clarithromycin, and tinidazole, given for 1 week, has been shown to be highly tolerable and effective, achieving a success rate of &amp;gt;90% in the adult population.<\/jats:p><jats:p>Objective.\u2003The aim of this study was to evaluate this short-term regimen in pediatric and adolescent populations.<\/jats:p><jats:p>Methods.\u2003The study group consisted of 35 children referred for evaluation of dyspeptic symptoms. They all underwent upper gastrointestinal endoscopy, in which H pylori infection was confirmed by rapid urease test and\/or histologic staining. They were given omeprazole (20 mg twice daily), clarithromycin (250 mg twice daily), and tinidazole or metronidazole (500 mg twice daily) for 1 week. The patients were divided into two groups: those who received the first course of anti-H pylori therapy during this study (group 1) and those who had previously received standard metronidazole and bismuth combination therapies that failed to eradicate H pylori (group 2). Therapeutic efficacy was assessed by a13C-urea breath test performed 4 weeks after completion of treatment.<\/jats:p><jats:p>Results.\u2003The 35 study patients had a mean age of 15.9 years (range, 10 to 19) and included 19 males and 16 females, of whom 22 were born in Israel and 13 were immigrants from the former USSR. There were 27 patients (77.1%) in group 1 and 8 patients (22.9%) in group 2. Endoscopic findings were nodular gastritis (14), gastritis (11), gastric ulcer (1), duodenal ulcer (5), and duodenitis (4).H pylori resolution was significantly higher in group 1 patients (24\/27, 88.9%) than in group 2 patients (1\/8, 12.5%). There was no difference between patients with nodular gastritis and those with nonnodular gastritis, and between Israeli-born patients and patients born in the former USSR. Compliance in both groups was equally good, and no major side effects were recorded.<\/jats:p><jats:p>Conclusions.\u2003One-week omeprazole\/clarithromycin\/tinidazole triple therapy is highly tolerable and effective for treating H pylori in the pediatric age group, but previous treatment failure diminishes the likelihood of success with this regimen.<\/jats:p>","DOI":"10.1542\/peds.102.1.e14","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:44:32Z","timestamp":1092440672000},"page":"e14-e14","source":"Crossref","is-referenced-by-count":14,"title":["One-Week Triple Therapy With Omeprazole, Clarithromycin, and Nitroimidazole for<i>Helicobacter pylori<\/i>Infection in Children and Adolescents"],"prefix":"10.1542","volume":"102","author":[{"given":"Menachem","family":"Moshkowitz","sequence":"first","affiliation":[{"name":"From the Department of Gastroenterology and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimon","family":"Reif","sequence":"additional","affiliation":[{"name":"Pediatric Gastrointestinal Unit, Dana Children's Hospital, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomo","family":"Brill","sequence":"additional","affiliation":[{"name":"From the Department of Gastroenterology and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Ringel","sequence":"additional","affiliation":[{"name":"From the Department of Gastroenterology and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadir","family":"Arber","sequence":"additional","affiliation":[{"name":"From the Department of Gastroenterology and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zamir","family":"Halpern","sequence":"additional","affiliation":[{"name":"From the Department of Gastroenterology and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoram","family":"Bujanover","sequence":"additional","affiliation":[{"name":"Pediatric Gastrointestinal Unit, Dana Children's Hospital, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[1998,7,1]]},"reference":[{"key":"2021121010154905200_B1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00005176-199205000-00008","article-title":"Helicobacter pylori infection in children: clinical, endoscopic and histologic correlations.","volume":"14","author":"Prieto","year":"1992","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"2021121010154905200_B2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00005176-199302000-00004","article-title":"Helicobacter pylori infection in children: potential clues to pathogenesis.","volume":"16","author":"Mitchell","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"2021121010154905200_B3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/000992289203100807","article-title":"Helicobacter pylori infection in children: a clinical overview.","volume":"8","author":"Glassman","year":"1992","journal-title":"Clin Pediatr."},{"key":"2021121010154905200_B4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0031-3955(05)70403-X","article-title":"Helicobacter pylori and peptic disease in the pediatric patient.","volume":"43","author":"Bujanover","year":"1996","journal-title":"Pediatr Clin North Am."},{"key":"2021121010154905200_B5","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198706183162501","article-title":"Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children.","volume":"316","author":"Drumm","year":"1987","journal-title":"N Engl J Med."},{"key":"2021121010154905200_B6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0022-3476(88)80030-1","article-title":"Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.","volume":"113","author":"Drumm","year":"1988","journal-title":"J Pediatr."},{"key":"2021121010154905200_B7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-3476(05)81536-7","article-title":"Treatment and long-term follow up of Helicobacter pylori-associated duodenal ulcer disease in children.","volume":"123","author":"Israel","year":"1993","journal-title":"J Pediatr."},{"key":"2021121010154905200_B8","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0140-6736(89)92206-X","article-title":"Amoxicillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by IgG antibody, pepsinogen 1, and gastrin levels.","volume":"1","author":"Oderda","year":"1989","journal-title":"Lancet."},{"key":"2021121010154905200_B9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/adc.64.3.326","article-title":"Campylobacter pylori gastritis: long term results of treatment with amoxicillin.","volume":"64","author":"Oderda","year":"1989","journal-title":"Arch Dis Child."},{"key":"2021121010154905200_B10","first-page":"1716","article-title":"Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori.","volume":"87","author":"Chiba","year":"1992","journal-title":"Am J Gastroenterol."},{"key":"2021121010154905200_B11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0016-5085(92)90095-G","article-title":"Factors influencing the eradication of Helicobacter pylori with triple therapy.","volume":"102","author":"Graham","year":"1992","journal-title":"Gastroenterology."},{"key":"2021121010154905200_B12","first-page":"1","article-title":"One-week low-dose triple therapy: new standards for Helicobacter pylori treatment.","volume":"7","author":"Goddard","year":"1995","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"2021121010154905200_B13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00042737-199409000-00004","article-title":"Short-term low-dose triple therapy for the eradication of Helicobacter pylori.","volume":"6","author":"Bazzoli","year":"1994","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"2021121010154905200_B14","first-page":"9","article-title":"One-week low-dose triple therapy for the eradication of Helicobacter pylori infection.","volume":"7","author":"Labenz","year":"1995","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"2021121010154905200_B15","first-page":"244","article-title":"Effective 2-wk therapy for Helicobacter pylori disease in children.","volume":"92","author":"Dohil","year":"1997","journal-title":"Am J Gastroenterol."},{"key":"2021121010154905200_B16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199302043280512","article-title":"Treatment of peptic ulcers caused by Helicobacter pylori.","volume":"328","author":"Graham","year":"1993","journal-title":"N Engl J Med."},{"key":"2021121010154905200_B17","first-page":"1149","article-title":"Campylobacter pylori-associated gastritis and peptic ulcer disease in children.","volume":"142","author":"Kilbridge","year":"1988","journal-title":"Am J Dis Child."},{"key":"2021121010154905200_B18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1365-2036.1996.96268000.x","article-title":"One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.","volume":"10","author":"Moshkowitz","year":"1996","journal-title":"Aliment Pharmacol Ther."},{"key":"2021121010154905200_B19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/gut.35.3.323","article-title":"Eradication of Helicobacter pylori with clarithromycin and omeprazole.","volume":"35","author":"Logan","year":"1994","journal-title":"Gut."},{"key":"2021121010154905200_B20","first-page":"A46","article-title":"Patient factors that predict failure of omeprazole, clarithromycin and tinidazole (OCT) to eradicate Helicobacter pylori (H. pylori).","volume":"37 (suppl)","author":"Moayyedi","year":"1995","journal-title":"Gut."},{"key":"2021121010154905200_B21","first-page":"259","article-title":"Coccoid-like forms (CLF) of Helicobacter pylori\u2014enzyme activity and antigenicity.","volume":"280","author":"Nilius","year":"1993","journal-title":"Int J Med Microbiol Virol Parasitol Infect Dis."},{"key":"2021121010154905200_B22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.90.4.608","article-title":"Contribution of the 13C-urea breath test to the detection of Helicobacter pylori gastritis in children.","volume":"4","author":"Vandenplas","year":"1992","journal-title":"Pediatrics."},{"key":"2021121010154905200_B23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0016-5085(95)90278-3","article-title":"Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection.","volume":"109","author":"Cutler","year":"1995","journal-title":"Gastroenterology."},{"key":"2021121010154905200_B24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/gut.36.6.845","article-title":"High Helicobacter pylori numbers are associated with low eradication rate after triple therapy.","volume":"36","author":"Moshkowitz","year":"1995","journal-title":"Gut."},{"key":"2021121010154905200_B25","first-page":"77","article-title":"The epidemiology and transmission of Helicobacter pylori infection in children.","volume":"9(suppl)","author":"Neale","year":"1995","journal-title":"Aliment Pharmacol Ther."},{"key":"2021121010154905200_B26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00005176-199007000-00008","article-title":"Nodular gastritis and Helicobacter pylori.","volume":"11","author":"Bujanover","year":"1990","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"2021121010154905200_B27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00004836-199604000-00017","article-title":"Antral nodularity, gastric lymphoid hyperplasia, and Helicobacter pylori in adults.","volume":"22","author":"Sbeih","year":"1996","journal-title":"J Clin Gastroenterol."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/102\/1\/e14\/837866\/e14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/102\/1\/e14\/837866\/e14.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T05:06:13Z","timestamp":1705208773000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/102\/1\/e14\/65407\/One-Week-Triple-Therapy-With-Omeprazole"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1998,7,1]]},"published-print":{"date-parts":[[1998,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.102.1.e14","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"type":"electronic","value":"1098-4275"},{"type":"print","value":"0031-4005"}],"subject":[],"published":{"date-parts":[[1998,7,1]]}}}